FindTrial
Sign In

Prospective clinical trial to obtain adequate blood draw for peripheral blood testing in high-risk neonates in neonatal intensive care units, we wanted to determine the optimal laser energy level (Laser energy level) of laser puncture devices.

Assessment of usability of capillary blood samplg by laser lancing device in in high-risk newborns in Neonatal Intensive Care Unit

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
CRIS
Registry ID
KCT0011037
Enrollment
200
Registered
2025-09-16
Start date
2023-12-15
Completion date
Unknown
Last updated
2025-11-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

None listed

Sponsors

Korea University Ansan Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: High-risk newborns admitted to the neonatal intensive care unit at Asan Medical Center, Seoul. Cases where peripheral blood tests are required using heel lancets. Confirmation of clinically hemodynamically stable condition.

Exclusion criteria

Exclusion criteria: congenital heart defects, severe respiratory distress (under artificial respiration), or other conditions affecting peripheral vascular filling time due to unstable hemodynamic status.

Design outcomes

Primary

MeasureTime frame
Clinical blood sampling effectiveness and pain assessment - Success is considered when approximately 100 µL of blood, the required blood sampling volume, is successfully collected.—

Secondary

MeasureTime frame
Wound area and healing process—

Countries

Korea, Republic of

Contacts

Public ContactChoi ByungMin

Korea University Ansan Hospital

cbmin15@gmail.com+82-31-412-5551

Outcome results

None listed

Source: CRIS (via WHO ICTRP) · Data processed: Feb 4, 2026